Patients with larger (T1b, >4 cm) renal cell carcinoma (RCC) not suitable for surgery have few treatment options as thermal ablation is less effective in this setting. We hypothesize that stereotactic ablative radiotherapy (SABR) represents an effective, safe, and nephron-sparing alternative for large RCC.